The Menarini Group Announces Commercial Agreement for Vabomere...
FLORENCE, Italy, Oct. 11, 2018 /PRNewswire-AsiaNet/ -- - Expands on existing commercial and co-development agreement for delafloxacin- Consolidates company's strategic focus on infectious diseasesThe Menarini Group, an Italian biopharmaceutical company present in 136 countries worldwide, a...
Read more https://view-release/?pr-id=75694